Latest News
- BREXIT: What does it mean for the Life Sciences? 1-Jun-2018
- New Committee Members 26-Feb-2018
- Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – one week away 10-May-2017
- Abstract and Bursary deadlines 31-Jan-2017: Big Data & the Development of New Medicines 30-Jan-2017
- Big Data & the Development of New Medicines 8-Dec-2016
Archives
- June 2018 (1)
- February 2018 (1)
- May 2017 (1)
- January 2017 (1)
- December 2016 (2)
- November 2016 (2)
- October 2016 (2)
- May 2016 (6)
- April 2016 (2)
- March 2016 (1)
- February 2016 (2)
- January 2016 (2)
- December 2015 (2)
- November 2015 (9)
- October 2015 (1)
- August 2015 (1)
- July 2015 (1)
- June 2015 (2)
- March 2015 (1)
- February 2015 (1)
- September 2014 (1)
- July 2014 (1)
- January 2014 (3)
- November 2013 (1)
- July 2013 (1)
- June 2013 (2)
- April 2013 (2)
- February 2013 (1)
- January 2013 (1)
- December 2012 (1)
- November 2012 (3)
- October 2012 (2)
- June 2012 (1)
- May 2012 (1)
- March 2012 (3)
- December 2011 (1)
- November 2011 (3)
- July 2011 (1)
- March 2011 (1)
Monthly Archives: October 2016
Exploratory medicines development – Innovation and risk management
First EUFEMED Conference Joint Meeting of European Human Pharmacological Societies Wednesday 17 May – Friday 19 May, 2017, London/UK Assessment and mitigation of risk are most challenging in exploratory drug development when a promising new compound is to be characterised … Continue reading
Comments Off on Exploratory medicines development – Innovation and risk management
Safety & Regulation in Early Clinical Drug Development, 02-Dec-2016
The BAPU (Belgian Association of Phase I Units) board is pleased to invite you to the BAPU Symposium: “Safety & Regulation in Early Clinical Drug Development”, which will take place on Friday December 2, 2016 at the Marriot Hotel in Gent. Please find … Continue reading
Comments Off on Safety & Regulation in Early Clinical Drug Development, 02-Dec-2016